← Eichor
Study identifier: NCT07373782 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3)  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhasePhase 2/Phase 3
Planned participants53
Who can joinFemale, 40 Years to 80 Years
Healthy volunteersNo

About this study

This study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with sleep apnea. The investigators expect a reduction in radiation doses to the heart and/or lungs with CPAP-supported radiotherapy compared to standard radiotherapy (without CPAP), which may also lead to a decrease in radiation-induced heart and/or lung conditions in the long term. The study will also examine how the use of a CPAP device can be implemented in daily radiotherapy practice.

This description comes directly from the study's public registry record.

Talk to the study team

Aline Van der Vorst, MD  ·  +3216340115  ·  aline.vandervorst@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

UZ LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07373782